Clinical Trial 40231


Long Beach, CA 90806

Study Summary:

A phase II, multicentered, randomized, double-blind, placebo-controlled, parallel-group, efficacy, and safety study of MTAU9937A in patients with prodromal to mild Alzheimer's disease


Qualified Participants Must:

• Patients aged between 50 and 80 years
• NIA-AA core clinical criteria for probable AD dementia

Qualified Participants May Receive:

Compensation for time and travel 

Research Site Profile

View Clinic Profile

Study is Available At:

CNS Network
2600 Redondo Ave.
Long Beach, CA 90806
View Clinic Location


If you or someone you care for is interested in participating in this clinical trial and lives within 50 miles of the clinic, please complete the form below and click 'I Am Interested In This Study'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.